Zanin Anna, Patti Matteo, Rosato Isabella, Divisic Antuan, Rusalen Francesca, Maghini Irene, Agosto Caterina, Benini Franca
Palliative Care and Pain Service, Department of Women's and Children's Health, University of Padua, Via Giustiniani 3, 35128, Padua, Italy.
Department of Women's and Children's Health, University of Padua, Padua, Italy.
Eur J Pediatr. 2025 Feb 12;184(3):194. doi: 10.1007/s00431-025-06020-z.
Trisomy 13 and 18 consist of a recurrent pattern of multiple congenital anomalies. The aim of this study was to analyze the clinical characteristics and disease trajectory of a cohort of children with trisomy 13 and 18 followed up by an Italian pediatric palliative care service.
A single-center retrospective observational study was conducted examining the medical records of patients with trisomy 13 and 18 seen in the Pediatric Palliatives Care (PPC) center of the University Hospital of Padua from 2007 to 2022.
Seventeen patients were included in the analysis. All were born alive; four children are still alive and only three (23%) died at home. All presented high care complexity, as estimated by ACCAPED index (median 86, range 38-129). The median time to receive care from PPC was 3 months (0-108). All patients' parents shared an advance care plan with the PPC team: 13/17 patients (76%) accepted a do not resuscitate (DNR) order. Approximately 12% of patients received at least one surgery. The trend of survival compared with other cohorts reported in the literature does not appear to differ significantly after the initial stages.
The possible recognition of an early evolution toward medical complexity and the availability of home care resources and programs are crucial factors in the management of these children. These indices could become a driving factor in the definition of new outcomes that are more patient-oriented, in addition to mortality.
• Trisomy 13 and 18 are serious genetic conditions with high mortality rates. In the last years medical interventions including surgery are being offered more frequently, though the appropriateness of these interventions is still debated.
• The study emphasizes the crucial role of early referral to specialized pediatric palliative care teams and the coordination they provide enabling families to care for their children at home, even with complex medical needs.
13三体和18三体综合征表现为多种先天性异常的反复出现模式。本研究的目的是分析一组由意大利儿科姑息治疗服务机构随访的13三体和18三体综合征患儿的临床特征和疾病发展轨迹。
进行了一项单中心回顾性观察研究,检查了2007年至2022年在帕多瓦大学医院儿科姑息治疗(PPC)中心就诊的13三体和18三体综合征患者的病历。
17名患者纳入分析。所有患者出生时均存活;4名儿童仍存活,只有3名(23%)在家中死亡。根据ACCAPED指数估计,所有患者的护理复杂性都很高(中位数86,范围38 - 129)。从PPC接受护理的中位时间为3个月(0 - 108)。所有患者的父母都与PPC团队共享了一份预先护理计划:13/17名患者(76%)接受了不进行心肺复苏(DNR)医嘱。约12%的患者接受了至少一次手术。与文献中报道的其他队列相比,初始阶段后的生存趋势似乎没有显著差异。
对向医疗复杂性早期演变的可能识别以及家庭护理资源和项目的可用性是管理这些儿童的关键因素。除死亡率外,这些指标可能成为定义更以患者为导向的新结局的驱动因素。
• 13三体和18三体综合征是严重的遗传疾病,死亡率很高。近年来,包括手术在内的医疗干预措施提供得越来越频繁,尽管这些干预措施的适当性仍存在争议。
• 该研究强调了早期转诊至专业儿科姑息治疗团队的关键作用,以及他们提供的协调作用,使家庭能够在家中照顾孩子,即使孩子有复杂的医疗需求。